Current Vascular Pharmacology

Editor-in-Chief:

Dimitri P. Mikhailidis  
Academic Head, Department of Clinical Biochemistry
Royal Free Hospital Campus
University College London Medical School
University College London (UCL)
Pond Street, London, NW3 2QG
UK

Back

Become EABM
Become Reviewer

The Management of Phosphodiesterase-5 (PDE5) Inhibitor Failure

Volume:4   Issue: 2
Pp: 89-93
David H.W. Lau, Sashi Kommu, Faiz H. Mumtaz, Robert J. Morgan, Cecil S. Thompson and Dimitri P. Mikhailidis
DOI: 10.2174/157016106776359871

Pharmacological Management of No Reflow During Percutaneous Coronary Intervention

Volume:4   Issue: 2
Pp: 95-100
Italo Porto, Vaishali Ashar and Andrew R.J. Mitchell
DOI: 10.2174/157016106776359835

Plasminogen Activator System and Vascular Disease

Volume:4   Issue: 2
Pp: 101-116
Suzanne M. Nicholl, Elisa Roztocil and Mark G. Davies
DOI: 10.2174/157016106776359880

Migraine: Current Therapeutic Targets and Future Avenues

Volume:4   Issue: 2
Pp: 117-128
D. K. Arulmozhi, A. Veeranjaneyulu and S. L. Bodhankar
DOI: 10.2174/157016106776359853

Pharmacotherapy of Abdominal Aortic Aneurysms

Volume:4   Issue: 2
Pp: 129-149
Joe Dawson, Edward Choke, Saiqa Sayed, Gillian Cockerill, Ian Loftus and Matt M. Thompson
DOI: 10.2174/157016106776359817

Fine Tuning Therapeutic Targeting of the Sphingolipid Biosynthetic Pathway to Treat Atherosclerosis

Volume:4   Issue: 2
Pp: 151-154
W. S. Kim, Charles E. Chalfant and Brett Garner
DOI: 10.2174/157016106776359844

Blood Pressure Reduction in the Primary and Secondary Prevention of Stroke

Volume:4   Issue: 2
Pp: 155-160
Seth I. Sokol, John R. Kapoor and JoAnne M. Foody
DOI: 10.2174/157016106776359862

Postprandial Hypotension - Novel Insights into Pathophysiology and Therapeutic Implications

Volume:4   Issue: 2
Pp: 161-171
Diana Gentilcore, Karen L. Jones, Deirdre G. O'Donovan and Michael Horowitz
DOI: 10.2174/157016106776359826